Previous phase | Next Phase
Continuing to improve your product’s market presence
As with any product that’s selling on the market, the management of a new drug is hardly complete once it launches. From continuing to learn about new developments in the market to quickly resolving issues that arise, there are plenty of things to keep manufacturers busy with their new treatments. It’s also vital that you stay on top of any new legal developments so that you don’t risk losing any of your state licenses.
It’s also important at the Growth phase to begin considering your loss of exclusivity strategy. How you handle the expiration of your patent can have a tremendous impact on the long-term value of your drug. Some manufacturers don’t begin thinking about this until they get close to that LOE date, but proper, early planning is imperative for maximizing the value of your product through its entire lifecycle.
Services We Recommend at
the Growth Phase
Commercialization
Compendia
Many see compendia databases as just a pricebook, but they’re so much more. In fact, an incorrect classification can mean a failed launch.
Learn More
State Licensing
In many ways, timely state licensing is just as important for your launch as the FDA approval process.
Learn More
EHRx Solutions
Expecting EHR visibility without a proactive and reactive approach equates to lost sales, especially with the prevalence of e-prescribing in today’s market.
Learn More
Learn More
Learn More
Learn More
Trade Management
From choosing the right 3PL partner to tracking and analyzing performance, optimizing your trade strategy is a significant part of commercial success.
Learn More
Learn More
Market Access
Payer Value Message Development and Testing
An engagement strategy that effectively communicates with payers to achieve favorable access is paramount to the successful launch of a product.
Learn More
Loss of Exclusivity
Strategy
Just as with launching a new product, managing a product’s loss of exclusivity (LOE) requires strategic planning and oversight.
Learn More
Patient Out of
Pocket Analysis
It’s imperative manufacturers have a thorough understanding of out of pocket (OOP) costs and the reimbursement support options available to them.
Learn More
Learn More
Learn More
Learn More
Payer Segmentation, Contracting and Plan by Plan Analysis
In today’s competitive landscape, a one-size-fits-all approach to your market access strategy is not enough.
Learn More
Learn More
Market Intelligence
Clinical Landscape &
Pipeline Analysis
Increase your awareness of your drug’s disease landscape and competitor activities to determine how to differentiate your drug in the market to be successful.
Learn More
Medical Congress
Coverage
Save time and money without losing out on important developments in the pharma world with our full medical congress coverage services.
Learn More
Qualitative Market
Research
Understand what physicians and patients want to see from your new product with our in-depth primary source interviewing services.
Learn More
Learn More
Learn More
Learn More
Commercial Organization Benchmarking
Gain the most from your benchmarking study with our key insights, complete with an action list and detailed recommendations.
Learn More
In-Licensing and
Acquisition Support
Our extensive experience monitoring and assessing all therapeutic categories allows us to provide insights to support licensing and acquisition decisions.
Learn More
Competitive
Simulations
Our Competitive Simulations are your key to deeper competitor insight and a smarter business development strategy.
Learn More
Learn More
Learn More
Learn More
Generic/Biosimilar
Outlook Assessment
Whether your drug is going off-patent soon or you are developing a new agent, gaining insight into other generics and biosimilars in development is critical.
Learn More
Learn More